Emergent Biosolutions Company Profile (NYSE:EBS)

About Emergent Biosolutions

Emergent Biosolutions logoEmergent BioSolutions Inc. is a biopharmaceutical company that offers specialized products to healthcare providers and governments to address medical needs and emerging health threats. The Company develops, manufactures and delivers a portfolio of medical countermeasures primarily for government agencies in the areas of biological and chemical threats and emerging infectious diseases (EID). It also develops and commercializes therapeutics in areas of hematology/oncology, transplantation, infectious diseases and autoimmune disorders. Its two operating divisions include Biodefense and Biosciences. The Biodefense division is a pharmaceutical business focused on countermeasures that address public health threats, including chemical, biological, radiological, nuclear and explosives (CBRNE) threats, as well as EID. The Biosciences division is a pharmaceutical business focused on therapeutics in hematology/oncology with secondary on transplantation, infectious disease and autoimmunity.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NYSE
  • Symbol: EBS
  • CUSIP: 29089Q10
Key Metrics:
  • Previous Close: $27.46
  • 50 Day Moving Average: $29.85
  • 200 Day Moving Average: $35.40
  • Trailing P/E Ratio: 19.64
  • Foreward P/E Ratio: 12.10
  • P/E Growth: 1.20
  • Market Cap: $1.11B
  • Outstanding Shares: 40,458,000
  • Beta: 1.3
Additional Links:
Companies Related to Emergent Biosolutions:

Analyst Ratings

Consensus Ratings for Emergent Biosolutions (NYSE:EBS) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $39.00 (42.02% upside)

Analysts' Ratings History for Emergent Biosolutions (NYSE:EBS)
Show:
DateFirmActionRatingPrice TargetDetails
8/7/2016Cowen and CompanyReiterated RatingHold$33.00View Rating Details
8/5/2016JPMorgan Chase & Co.Lower Price TargetOverweight$45.00 -> $36.00View Rating Details
6/28/2016Singular ResearchLower Price TargetBuy$44.00 -> $40.00View Rating Details
6/22/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
5/2/2016Chardan CapitalReiterated RatingBuyView Rating Details
3/6/2015Summer StreetReiterated RatingBuy$35.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for Emergent Biosolutions (NYSE:EBS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q2($0.17)($0.18)$111.20 million$101.49 millionViewListenView Earnings Details
5/5/2016Q1($0.07)$0.16$101.83 million$111.00 millionViewListenView Earnings Details
2/25/2016Q4$0.70$0.78$168.07 million$168.10 millionViewListenView Earnings Details
11/5/2015Q315$0.55$0.83$151.42 million$164.90 millionViewListenView Earnings Details
8/6/2015Q215$0.18$0.36$114.25 million$126.10 millionViewListenView Earnings Details
5/7/2015Q1($0.45)($0.50)$62.70 million$63.60 millionViewListenView Earnings Details
3/5/2015Q115$0.69$0.75$147.00 million$148.00 millionViewListenView Earnings Details
11/6/2014Q414$0.52$0.49$126.90 million$138.00 millionViewListenView Earnings Details
8/7/2014Q214$0.32$0.25$109.25 million$110.30 millionViewListenView Earnings Details
5/8/2014Q114($0.14)($0.55)$57.30 million$53.90 millionViewListenView Earnings Details
3/6/2014Q413$0.36$0.42$93.83 million$94.10 millionViewListenView Earnings Details
11/7/2013Q313$0.21$0.37$79.13 million$89.10 millionViewListenView Earnings Details
8/5/2013Q2 2013$0.21$0.29$75.73 million$82.40 millionViewListenView Earnings Details
5/2/2013Q1 2013($0.14)($0.22)$46.17 million$43.10 millionViewListenView Earnings Details
3/7/2013Q4 2012$0.44$0.44$95.09 million$94.61 millionViewListenView Earnings Details
11/1/2012Q312$0.22$0.18$73.53 million$66.60 millionViewN/AView Earnings Details
8/2/2012$0.21$0.21ViewN/AView Earnings Details
5/3/2012($0.18)($0.19)ViewN/AView Earnings Details
3/8/2012$0.72$0.78ViewN/AView Earnings Details
11/3/2011($0.04)$0.04ViewN/AView Earnings Details
8/4/2011$0.33$0.40ViewN/AView Earnings Details
5/5/2011($0.52)($0.64)ViewN/AView Earnings Details
3/10/2011$0.67$0.76ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Emergent Biosolutions (NYSE:EBS)
Current Year EPS Consensus Estimate: $1.23 EPS
Next Year EPS Consensus Estimate: $2.27 EPS

Dividends

Dividend History for Emergent Biosolutions (NYSE:EBS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Emergent Biosolutions (NYSE:EBS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/6/2016George A JoulwanDirectorSell4,700$44.12$207,364.00View SEC Filing  
6/1/2016Daniel Abdun-NabiCEOSell8,699$43.74$380,494.26View SEC Filing  
5/27/2016Fuad El-HibriMajor ShareholderSell9,835$43.50$427,822.50View SEC Filing  
5/26/2016Fuad El-HibriMajor ShareholderSell39,759$43.13$1,714,805.67View SEC Filing  
5/25/2016Fuad El-HibriMajor ShareholderSell85,000$42.52$3,614,200.00View SEC Filing  
5/25/2016Zsolt HarsanyiDirectorSell27,867$42.33$1,179,610.11View SEC Filing  
5/24/2016Fuad El-HibriChairmanSell20,000$42.26$845,200.00View SEC Filing  
5/23/2016Fuad El-HibriChairmanSell45,000$42.62$1,917,900.00View SEC Filing  
5/20/2016Daniel Abdun-NabiCEOSell8,701$42.00$365,442.00View SEC Filing  
5/19/2016Jerome M HauerDirectorSell3,134$41.22$129,183.48View SEC Filing  
5/13/2016Louis W SullivanDirectorSell47,631$39.21$1,867,611.51View SEC Filing  
5/12/2016Fuad El-HibriMajor ShareholderSell25,000$38.71$967,750.00View SEC Filing  
5/12/2016Jerome M HauerDirectorSell4,700$38.50$180,950.00View SEC Filing  
5/11/2016Louis W SullivanDirectorSell9,969$39.25$391,283.25View SEC Filing  
4/22/2016Fuad El-HibriMajor ShareholderSell4,209$40.50$170,464.50View SEC Filing  
4/18/2016Daniel Abdun-NabiCEOSell8,702$40.17$349,559.34View SEC Filing  
4/18/2016Fuad El-HibriMajor ShareholderSell20,791$40.50$842,035.50View SEC Filing  
4/6/2016Fuad El-HibriMajor ShareholderSell50,000$39.00$1,950,000.00View SEC Filing  
4/6/2016Robert KramerEVPSell21,786$38.90$847,475.40View SEC Filing  
4/4/2016Robert KramerEVPSell21,788$36.90$803,977.20View SEC Filing  
4/1/2016Robert KramerEVPSell43,572$35.56$1,549,420.32View SEC Filing  
3/14/2016Adam HaveyEVPSell4,359$33.96$148,031.64View SEC Filing  
3/14/2016Jerome M HauerDirectorSell2,350$33.88$79,618.00View SEC Filing  
3/11/2016Adam HaveyEVPSell11,112$33.84$376,030.08View SEC Filing  
3/11/2016Louis W SullivanDirectorSell14,879$34.03$506,332.37View SEC Filing  
3/7/2016Marvin L WhiteDirectorSell33,134$35.42$1,173,606.28View SEC Filing  
1/4/2016Sue BaileyDirectorSell11,520$38.79$446,860.80View SEC Filing  
12/30/2015Ronald RichardDirectorSell21,600$40.00$864,000.00View SEC Filing  
12/24/2015Daniel Abdun-NabiCEOSell63,209$39.06$2,468,943.54View SEC Filing  
11/19/2015Fuad El-Hibrimajor shareholderSell17,871$37.50$670,162.50View SEC Filing  
11/13/2015Fuad El-Hibrimajor shareholderSell13,013$36.50$474,974.50View SEC Filing  
11/12/2015Barry LabingerEVPSell36,126$35.64$1,287,530.64View SEC Filing  
11/9/2015Fuad El-Hibrimajor shareholderSell13,225$35.50$469,487.50View SEC Filing  
11/6/2015Fuad El-Hibrimajor shareholderSell13,450$34.50$464,025.00View SEC Filing  
11/3/2015Fuad El-Hibrimajor shareholderSell13,689$33.50$458,581.50View SEC Filing  
9/11/2015Sue BaileyDirectorSell6,080$32.37$196,809.60View SEC Filing  
8/13/2015George A JoulwanDirectorSell7,200$34.72$249,984.00View SEC Filing  
7/20/2015Fuad El-HibriChairmanSell234$34.50$8,073.00View SEC Filing  
7/13/2015Ronald RichardDirectorSell4,922$34.00$167,348.00View SEC Filing  
6/29/2015Ronald RichardDirectorSell4,923$32.76$161,277.48View SEC Filing  
6/22/2015Fuad El-HibriMajor ShareholderSell74,564$32.60$2,430,786.40View SEC Filing  
6/16/2015Louis W SullivanDirectorSell13,457$31.33$421,607.81View SEC Filing  
6/15/2015Adam HaveyEVPSell36,298$31.55$1,145,201.90View SEC Filing  
6/15/2015Fuad El-HibriMajor ShareholderSell45,436$32.18$1,462,130.48View SEC Filing  
1/20/2015Fuad El-HibriMajor ShareholderSell15,325$27.67$424,042.75View SEC Filing  
12/26/2014Ronald RichardDirectorSell5,000$28.00$140,000.00View SEC Filing  
12/17/2014Ronald RichardDirectorSell5,000$27.00$135,000.00View SEC Filing  
12/11/2014Fuad El-HibriMajor ShareholderSell119,341$26.00$3,102,866.00View SEC Filing  
11/28/2014Fuad El-HibriMajor ShareholderSell34,577$25.00$864,425.00View SEC Filing  
11/25/2014Fuad El-HibriMajor ShareholderSell9,014$25.00$225,350.00View SEC Filing  
11/25/2014Zsolt HarsanyiDirectorSell8,000$24.82$198,560.00View SEC Filing  
11/12/2014Fuad El-HibriMajor ShareholderSell2,311$25.00$57,775.00View SEC Filing  
11/7/2014Robert KramerCFOSell2,625$24.00$63,000.00View SEC Filing  
4/16/2014Robert KramerCFOSell50,189$24.34$1,221,600.26View SEC Filing  
3/12/2014Adam HaveyEVPSell11,562$27.50$317,955.00View SEC Filing  
3/11/2014Adam HaveyEVPSell17,655$26.96$475,978.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Emergent Biosolutions (NYSE:EBS)
DateHeadline
4-traders.com logoPurcell Julie & Lefkowitz LLP : Is Investigating Emergent BioSolutions Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (NYSE:EBS)
www.4-traders.com - August 28 at 9:17 AM
News IconSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of Commencement of a Class Action... (NYSE:EBS)
ih.advfn.com - August 27 at 8:56 AM
prnewswire.com logoPurcell Julie & Lefkowitz LLP Is Investigating Emergent BioSolutions Inc. for Potential Breaches Of Fiduciary Duty ... - PR Newswire (press release) (NYSE:EBS)
www.prnewswire.com - August 26 at 4:04 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 19, 2016 (NYSE:EBS)
finance.yahoo.com - August 26 at 4:04 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 26 at 4:04 PM
finance.yahoo.com logoPurcell Julie & Lefkowitz LLP Is Investigating Emergent BioSolutions Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (NYSE:EBS)
finance.yahoo.com - August 26 at 4:04 PM
finance.yahoo.com logoINVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 26 at 4:04 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Emergent Biosolutions, Inc (EBS) and Lead Plaintiff Deadline: September 19, 2016 (NYSE:EBS)
finance.yahoo.com - August 23 at 4:51 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 23 at 4:51 PM
4-traders.com logoLundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:EBS)
www.4-traders.com - August 23 at 8:57 AM
News IconEBS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Emergent Bi... (NYSE:EBS)
ih.advfn.com - August 22 at 4:47 PM
finance.yahoo.com logoBrower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Those with Substantial Losses from Investment in Emergent BioSolutions, Inc. to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 21 at 9:16 AM
4-traders.com logoKhang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
www.4-traders.com - August 20 at 4:42 PM
finance.yahoo.com logoEQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 20 at 4:42 PM
News IconEMERGENT SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Exce... (NYSE:EBS)
ih.advfn.com - August 20 at 8:11 AM
finance.yahoo.com logoEMERGENT SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Emergent Biosolutions, Inc. - EBS (NYSE:EBS)
finance.yahoo.com - August 20 at 8:11 AM
investornewswire.com logoWill Emergent Biosolutions, Inc. (NYSE:EBS) Hit $47 Price Target? - Investor Newswire (NYSE:EBS)
www.investornewswire.com - August 19 at 8:01 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 17 at 10:02 PM
finance.yahoo.com logoEBS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action … (NYSE:EBS)
finance.yahoo.com - August 17 at 4:54 PM
finance.yahoo.com logoEBS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Emergent Biosolutions Inc. and a Lead Plaintiff Deadline of September 19, 2016 (NYSE:EBS)
finance.yahoo.com - August 17 at 4:54 PM
finance.yahoo.com logoINVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 17 at 7:16 AM
4-traders.com logoEmergent BioSolutions : Receives FDA Approval for Large-Scale Manufacturing of BioThrax in Building 55 (NYSE:EBS)
www.4-traders.com - August 16 at 4:48 PM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Emergent Biosolutions, Inc (EBS) and Lead Plaintiff Deadline: September 19, 2016 (NYSE:EBS)
finance.yahoo.com - August 16 at 4:48 PM
finance.yahoo.com logoEMERGENT BIOSOLUTIONS INC. Financials (NYSE:EBS)
finance.yahoo.com - August 16 at 4:48 PM
finance.yahoo.com logoEmergent BioSolutions Receives FDA Approval for Large-Scale ... - Yahoo Finance (NYSE:EBS)
finance.yahoo.com - August 16 at 8:00 AM
finance.yahoo.com logoSHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 16 at 8:00 AM
News IconSHAREHOLDER ALERT: Holzer & Holzer Files Securities Class Action Lawsuit Against Emergent BioSolutions; Reminds Investors of ... (NYSE:EBS)
ih.advfn.com - August 15 at 4:54 PM
publicnow.com logoEmergent BioSolutions Receives FDA Approval for Large-Scale Manufacturing of BioThrax in Building 55 (NYSE:EBS)
www.publicnow.com - August 15 at 4:54 PM
4-traders.com logoEmergent BioSolutions : Announces Conversion Rate Adjustment to 2.875% Convertible Senior Notes Due 2021 Following Spin-Off of Aptevo Therapeutics (NYSE:EBS)
www.4-traders.com - August 13 at 4:40 PM
publicnow.com logoEmergent BioSolutions Announces Conversion Rate Adjustment to 2.875% Convertible Senior Notes Due 2021 Following Spin-Off of Aptevo Therapeutics (NYSE:EBS)
www.publicnow.com - August 12 at 9:55 PM
fidaily.com logoEmergent Biosolutions, Inc. Com (EBS) Saw a New 52-Week Low - Finance Daily (NYSE:EBS)
www.fidaily.com - August 12 at 4:47 PM
fidaily.com logoEmergent Biosolutions, Inc. Com (EBS) Saw a New 52-Week Low - Finance Daily (NYSE:EBS)
www.fidaily.com - August 12 at 4:47 PM
globenewswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ... - GlobeNewswire (press release) (NYSE:EBS)
globenewswire.com - August 12 at 4:47 PM
globenewswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ... - GlobeNewswire (press release) (NYSE:EBS)
globenewswire.com - August 12 at 4:47 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 19, 2016 – EBS (NYSE:EBS)
finance.yahoo.com - August 12 at 4:47 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 19, 2016 – EBS (NYSE:EBS)
finance.yahoo.com - August 12 at 4:47 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS (NYSE:EBS)
finance.yahoo.com - August 12 at 4:47 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS (NYSE:EBS)
finance.yahoo.com - August 12 at 4:47 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 12 at 4:47 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 12 at 4:47 PM
finance.yahoo.com logoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions, … (NYSE:EBS)
finance.yahoo.com - August 11 at 10:36 PM
finance.yahoo.com logoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions, Inc. Investors and Encourages Investors to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 11 at 4:53 PM
capitalcube.com logoETF’s with exposure to Emergent BioSolutions, Inc. : August 11, 2016 (NYSE:EBS)
www.capitalcube.com - August 11 at 4:53 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Emergent Biosolutions, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit – EBS (NYSE:EBS)
finance.yahoo.com - August 11 at 4:53 PM
fool.com logoEmergent BioSolutions Inc. Asks for Patience (NYSE:EBS)
www.fool.com - August 11 at 4:53 PM
finance.yahoo.com logoDEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - August 11 at 4:53 PM
publicnow.com logoErste Bank Expands Micro-Credit Program (NYSE:EBS)
www.publicnow.com - August 11 at 7:58 AM
bizjournals.com logoAltimmune nabs $120.2 million federal contract for nasal spray anthrax vaccine (NYSE:EBS)
www.bizjournals.com - August 10 at 10:56 PM
publicnow.com logoCDC Exercises Contract Option Valued at $11.6 Million to Further Support Emergent BioSolutions’ Vaccinia Immune Globulin (NYSE:EBS)
www.publicnow.com - August 10 at 11:59 AM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Emergent Biosolutions, Inc (EBS) and Lead Plaintiff Deadline: September 19, 2016 (NYSE:EBS)
finance.yahoo.com - August 9 at 3:24 PM

Social

Emergent Biosolutions (NYSE:EBS) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff